Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/106442
Title: | Effect of glucocorticoid treatment on computed tomography angiography detected large-vessel inflammation in giant-cell arteritis. A prospective, longitudinal study. |
Author: | Prieto González, Sergio García Martínez, Ana Tavera Bahillo, Itziar Hernández Rodríguez, José Gutiérrez Chacoff, José Alba, Marco A. Murgia, Giuseppe Espígol Frigolé, Georgina Sánchez, Marcelo Arguis, Pedro Cid Xutglà, M. Cinta |
Keywords: | Glucocorticoides Arteritis de cèl·lules gegants Efectes secundaris dels medicaments Tomografia computada per emissió de fotó simple Glucocorticoids Giant cell arteritis Drug side effects Single-photon emission computed tomography |
Issue Date: | Feb-2015 |
Publisher: | Lippincott, Williams & Wilkins. Wolters Kluwer Health |
Abstract: | Computed tomography angiography (CTA) detects signs of large-vessel vasculitis (LVV) in about 67.5% of patients with giant-cell arteritis (GCA) at the time of diagnosis and early aortic dilatation in 15%. The outcome of CTA-findings of LVV upon glucocorticoid treatment has not been prospectively evaluated. The aim of our study was to prospectively assess glucocorticoid-induced changes in CTA findings of LVV in patients with GCA. Forty biopsy-proven GCA patients evaluated by CTA at diagnosis were prospectively followed and scheduled a new CTA approximately after 1 year of treatment. Vessel wall thickening, diameter, and contrast enhancement of the aorta and its tributaries were evaluated. Results were compared to those obtained at the time of diagnosis. CTA was repeated to 35 patients after a median follow-up of 13.5 months (IQ25-75% 12.4-15.8). Arterial wall thickening was still present in 17 patients (68% of the patients who initially had LVV). The number of affected segments and wall thickness at various aortic segments significantly decreased and no patients developed new lesions, new aortic dilation or increase in previous dilation. Contrast enhancement disappeared in 15 (93.75%) of 16 patients in whom this finding could be assessed. Signs of LVV improve with treatment. While contrast enhancement resolves in the majority of patients, vessel wall thickening persists in two thirds. However, the number of affected aortic segments as well as aortic wall thickness significantly decreases. Longer follow-up is necessary to determine the clinical significance of persisting wall thickening and its relationship with relapses or subsequent development of aortic dilatation or large-vessel stenoses. |
Note: | Reproducció del document publicat a: https://doi.org/10.1097/MD.0000000000000486 |
It is part of: | Medicine, 2015, vol. 94, num. 5, p. e486 |
URI: | http://hdl.handle.net/2445/106442 |
Related resource: | https://doi.org/10.1097/MD.0000000000000486 |
ISSN: | 0025-7974 |
Appears in Collections: | Articles publicats en revistes (Medicina) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
651026.pdf | 345.46 kB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License